The Guardant360® test has been ordered over 100,000 times by more than 7,000 oncologists worldwide and has been validated in over 150 peer-reviewed publications. Our liquid biopsy test can help guide treatment decisions and favourably impact the lives of advanced cancer patients in Asia, Middle East and Africa. Check out our patient brochure by clicking on the link below.
Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at firstname.lastname@example.org or contact us on WhatsApp: +65 8940 0360.
Guardant360®. Test. Take Action.